Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,180
Total Claims
$176K
Drug Cost
124
Beneficiaries
$1,420
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+33%
Cost per patient vs peers
$1,420 vs $1,068 avg
+8%
Brand preference vs peers
9.7% vs 9.0% avg
Brand vs Generic
Brand: 886 claims · $111K
Generic: 8,263 claims · $65K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 248 | $37K |
| Rivaroxaban | 116 | $16K |
| Insulin Degludec | 41 | $6,225 |
| Linagliptin | 44 | $5,608 |
| Sitagliptin Phosphate | 39 | $5,321 |
| Empagliflozin | 32 | $5,306 |
| Mirabegron | 34 | $3,831 |
| Atorvastatin Calcium | 651 | $3,596 |
| Sacubitril/Valsartan | 21 | $3,500 |
| Midodrine Hcl | 103 | $3,312 |
| Insulin Glargine,hum.Rec.Anlog | 32 | $3,082 |
| Pantoprazole Sodium | 300 | $2,464 |
| Furosemide | 574 | $2,238 |
| Memantine Hcl | 60 | $2,142 |
| Amlodipine Besylate | 518 | $2,054 |
Prescribing Profile
Patient Profile
78
Avg Age
52%
Female
2.77
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data